Attach 2 - Consultants

Attach 2 - Consultants.docx

A multi-center international hospital-based case-control study of lymphoma in Asia (AsiaLymph) (NCI)

Attach 2 - Consultants

OMB: 0925-0654

Document [docx]
Download: docx | pdf

Attachment 2: Consultants for AsiaLymph


Outside Consultants


  1. Dennis D. Weisenburger, MD
    Professor, Director, Hematopathology
    Chief Pathologist, Nebraska Lymphoma Study Group
    Department of Pathology and Microbiology
    University of Nebraska Medical Center
    983135 Nebraska Medical Center
    Omaha, NE 68198-3135
    Tel: 402-559-7688
    Fax: 402-559-6018
    Email: [email protected]


Dr. Weisenburger is one of the world’s leading lymphoma pathologists and has been consulted on the study multiple times, most recently in 2010.



  1. Shelia Hoar Zahm, Sc.D.

Former Deputy Director

Division of Cancer Epidemiology and Genetics

National Cancer Institute, NIH, DHHS

6120 Executive Boulevard, EPS 8074

Rockville, MD 20892-7242

Tel: (301) 496-8157

Mobile: (301) 502-2090

Fax: (301) 402-3256

Email: [email protected]


Dr. Zahm is one of the world’s leading experts on the epidemiology of lymphoma. She hasbeen consulted on the study multiple times between 2009-2012. She is currently a consultant to DCEG.


  1. Roel Vermeulen, PhD

Senior Investigator

Institute for Risk Assessment sciences

Utecht Univeristy

Jenalaan 18D

3584 CK Utrecht

The Netherlands

Tel: +030 254 9448

Email: [email protected]


Dr. Vermeulen is an international expert on exposure assessment methods for occupational and environmental exposure assessment and was consulted multiple times from 2009-2012.


  1. Troy Sadkowsky

Brisbane, Australia

Email: [email protected]; [email protected]

Mobile: +614 02453168


Mr. Troy Sadkowsky is an expert consultant on computer programming for OccIDEAAS and has been regularly consulted on the project in 2011 and 2012.


  1. John Chan, MD

Consultant Pathologist

Queen Elizabeth Hospital

Wylie Road

Kowloon Hong Kong

Tel: (852) 2958 6830

e-mail: [email protected]


Dr. John Chan is one of the leading lymphoma pathologists in Asia and in the world, who is a member of the WHO committee on lymphoma classification. He has been consulted on the study multiple times between 2009 to 2012.


  1. Raymond Liang, MD

Director, Comprehensive Oncology Centre
Director, Haematology Centre

Hong Kong Sanatorium & Hospital

2 Village Road, Happy Valley, Hong Kong   

Tel : 852-2572 0211   

Cell: 852-519-22-313

e-mail: [email protected]


Dr. Liang is one of the leading lymphoma clinicians in Asia and has been consulted multiple times on the study from 2009-2012.


National Cancer Institute (NCI) Investigators Responsible For Study Management, Coordination and Statistical Analysis

Qing Lan, Senior Investigator, (301-435-4706)

Lindsay Morton, Investigator, Senior Investigator, (301-435-3972)

Martha Linet, Senior Investigator, (301-496-6600)

Alina Brenner , Staff Scientist, (301-402-8680)

Charles Rabkin, Senior Investigator, (301-435-4731)

Mark Purdue, Senior Investigator, (301-451-5036)

Lynn Goldin, Senior Investigator, (301-402-9656)

Neil Caporaso, Senior Investigator, (301-496-4377)

Stephen Chanock, Senior Investigator, (301-435-7559)

Melissa Friesen, Investigator, (301-594-7485)

Mary Ward, Senior Investigator, (301-435-4713)

Sholom Wacholder, Senior Investigator, (301-496-3358)

Kai Yu, Senior Investigator, (301-594-7206)

Wei Hu, Post-doctoral Fellow, (301-594-1613)

4


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleATTACHMENT 1
Authorpctech_temp
File Modified0000-00-00
File Created2021-01-31

© 2024 OMB.report | Privacy Policy